Epigenetic dysregulation in neurodegenerative diseases and potential treatment

Epigenetic dysregulation in neurodegenerative diseases and potential treatment

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Bibliografske podrobnosti
Glavni avtor:	Mostofa, Golam
Drugi avtorji:	Khan, Tanisha Tabassum Sayka
Format:	Thesis
Jezik:	English
Izdano:	Brac University 2022
Teme:	Epigenetics Dysregulation Methylation Acetylation Alzheimer’s disease Parkinson’s disease Huntington’s disease Epidrugs
Online dostop:	http://hdl.handle.net/10361/17309

Podobne knjige/članki

Potential treatments for epigenetic dysregulation in neurological diseases
od: Zaman, Rubaiyat
Izdano: (2024)

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
od: Dey, Manashi
Izdano: (2024)

Gene editing for neurodegenerative diseases-A review
od: Sharna, Anika Islam
Izdano: (2023)

Role of epigenetics in the development of metabolic disorders: a review
od: Mita, Tanzia Mohsin
Izdano: (2024)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
od: Alim, Abdul
Izdano: (2023)

Impact of Lifestyle on the Disease Progression of Parkinson’s
od: Annee, Israt Jahan
Izdano: (2023)

Role of circular RNA in neurological disease
od: Salsabil, Labiba
Izdano: (2024)

Parkinson’s disease and COVID-19: treatment and patient management during a pandemic
od: Afsana, Nourin
Izdano: (2022)

Diagnostic biomarkers of Parkinson’s disease: The present and the future
od: Ferdous, Labiba
Izdano: (2023)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
od: Chowdhury, Sariya Uzrat
Izdano: (2022)

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
od: Tabassum, Nadira
Izdano: (2024)

Role of protein’s and future treatment options for Alzheimer’s Disease
od: Islam, Md. Irfath
Izdano: (2023)

A review on cardiovascular development and epigenetics
od: Srity, Nafisa Alam
Izdano: (2024)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
od: Shehab, Habibul Mohsin
Izdano: (2024)

Treatment options of Parkinson’s disease: How far we are from the cure?
od: Afreen, Nuraia
Izdano: (2021)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
od: Tamanna, Mst. Taskia
Izdano: (2023)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
od: Karmaker, Swastika
Izdano: (2024)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
od: Tasneem, Sadia
Izdano: (2021)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
od: Ishrat, Nowshin
Izdano: (2024)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
od: Saha, Bithi Rani
Izdano: (2023)

Parkinson's disease in Bangladesh: An evaluation of the public knowledge and awareness
od: Chowdhury, Amal
Izdano: (2024)

Marine compounds in the treatment of Alzheimer’s disease
od: Parveen, Sanjana
Izdano: (2022)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
od: Hassan, Md. Muhtaz
Izdano: (2020)

Review on: the mechanism and function of Glia in parkinson's disease
od: Abedin, Khondokar Mezbahul
Izdano: (2023)

Alzheimer's disease and marriage : an intimate account /
od: Wright, Lore K.
Izdano: (1993)

Therapeutic implication of senescent cell elimination in neurodegenerative diseases
od: Key, Nasrin Sultana
Izdano: (2023)

Emerging therapies of Alzheimer’s disease: a comprehensive review
od: Tasin, Md Abtahi
Izdano: (2023)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
od: Aziz, Farhin
Izdano: (2019)

Early detection of parkinson’s disease using image processing and artificial neural network
od: Rumman, Mosarrat, et al.
Izdano: (2018)

Prospective detection methods for Tau protein: an important biomarker for Alzheimer’s disease
od: Afra, Sumaiya
Izdano: (2022)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
od: Bakar, Osama Bin Abu
Izdano: (2024)

Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
od: Mahee, Sadique Abdal
Izdano: (2024)

A look into parkinson’s disease and the implications of gene therapy as a novel clinical approach
od: Islam, Md. Rakibul
Izdano: (2023)

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
od: Halim, Rabea
Izdano: (2022)

Exploring the role of programmed cell death protein 1 in alzheimer’s disease associated autoimmunity
od: Aana, Afsara Sumon
Izdano: (2021)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
od: Haque, Mushfiqul
Izdano: (2019)

A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
od: Jahan, Nusrat
Izdano: (2023)

Infection and communicable diseases /
od: Brettle, Raymond Patrick
Izdano: (1984)

Exploring Alzheimer's disease prediction with XAI in various neural network models
od: Rahman, Quazi Ashikur, et al.
Izdano: (2022)

Exploring the potential of organic molecules in the treatment of covid-19
od: Mondol, Winifred Claire
Izdano: (2024)